Updated:2024-11-24 03:10 Views:131
A patient holds up a dosage of Wegovy, a blockbuster drug used for weight loss. —AP Photo/Amanda Andrade-Rhoades, File
NEW MEXICO, United States — Unlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them.
The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost.
Article continues after this advertisementFor Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her.
FEATURED STORIES GLOBALNATION World leaders divided over ICC arrest warrant on Netanyahu GLOBALNATION Singapore hangs third drug trafficker in a week GLOBALNATION Judge in Trump criminal case delays sentencing indefinitelyREAD: My life on Ozempic, the so-called weight-loss ‘miracle drug’
“I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.”
Article continues after this advertisementIn clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15 percent to 22 percent of their body weight—up to 50 pounds or more in many cases. But roughly 10 percent to 15 percent of patients in those trials were “nonresponders” who lost less than 5 percent of their body weight.
Article continues after this advertisement 1 in 5 may not respond wellNow that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20 percent of patients—as many as 1 in 5—may not respond well to the medications. It’s a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results.
Article continues after this advertisement“It’s all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital
The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person’s response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives.
Article continues after this advertisement“This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient.
Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge.
“It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.”
That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight.
“It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.”
The medications are typically prescribed along with eating behavior and lifestyle changes.
It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases.
For some patients, that just doesn’t happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options.
‘It’s not game over’“I tell them: It’s not game over,” Dushay said.
Trying a different version of the new class of drugs may help. Griffin, who didn’t respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds.
“I’m hoping it’s slow and steady,” she said.
Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted.
Subscribe to our daily newsletter
“Obesity is such a complex disease that really needs to be treated very comprehensivelybilyonaryo online casino,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.”
READ NEXT Even with access to new obesity drugs, some people don’t los... 75 Filipinos flying out of Lebanon; total repats reach 1,191 EDITORS' PICK NBA: 76ers’ Joel Embiid sidelined due to left knee swelling Gaetz is gone? In these times, Trump’s bro culture trumps rape Sara Duterte’s kill remark vs Marcos is ‘active threat’ – Palace UAAP: NU Lady Bulldogs sweep their way back to UAAP Finals 19-year-old arrested in shooting deaths of Fil-Am siblings inside burning home ‘Hello, Love, Again’ earns P930 million, now the highest grossing PH film MOST READ Asean defense ministers renew push for code of conduct Sara Duterte blocks execution of House order on Lopez detention change NDC chief resigns, plans return to private sector Solons react to Sara 'kill order' video: VP needs psycho evaluation Follow @FMangosingINQ on Twitter --> View comments 上一篇：22fun PVL: Creamline turns back Akari in Tots Carlos’ return
下一篇：satta9 Seventeen, aespa among biggest winners at MAMA Awards 2024